EMCURE DRHP PDF

Pune-based Emcure Pharmaceuticals has pulled out its proposed red herring prospectus or DRHP with securities market regulator SEBI. Emcure Pharmaceuticals on Wednesday said it has filed a draft red herring prospectus (DRHP) with the Sebi for launching an initial public offer. Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus ( DRHP) with SEBI for initial public offering that includes fresh issue.

Author: Tumi Shajora
Country: Congo
Language: English (Spanish)
Genre: Automotive
Published (Last): 15 November 2006
Pages: 91
PDF File Size: 4.32 Mb
ePub File Size: 3.83 Mb
ISBN: 442-3-19256-829-3
Downloads: 20553
Price: Free* [*Free Regsitration Required]
Uploader: Zoloran

Deepti Chaudhary Malvika Joshi. This will alert our moderators to take action Name Reason for reporting: Book running lead managers to the issue include Bank of America Merrill Lynch.

Emcure is a fast growing Indian pharmaceutical company engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally. Sensex finishes year above 36, posts third straight annual gain. Emcure is ranked as the 14th-largest pharmaceutical company in India in terms of market share based on the domestic sales of pharmaceutical products. Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings.

Drag according to your convenience. The pharma company intends to utilise the net proceeds for setting up of new manufacturing facilities and expansion of existing manufacturing facilities; research and development; and general corporate purposes.

Emcure becomes the first proposed IPO to be withdrawn after the election results and the fourth since January 1 this year.

Emcure Pharmaceuticals withdraws proposed IPO | VCCircle

By Jasleen Kaur Batra. Promoter Satish Ramanlal Mehta holds In AprilEmcure acquired Heritage Pharmaceuticals, a New Jersey-based generic pharmaceutical company, which provided it emchre commercial platform to market and sell its products. The company is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally.

  EPIDEMIJA POPUSTLJIVOG ODGOJA PDF

In AprilEmcure acquired Heritage Pharmaceuticals, a New Jersey-based generic pharmaceutical company, which provided it a commercial platform to market and sell its products. Log in Keep me signed in. Infibeam calls off pact to acquire Snapdeal unit Unicommerce. These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients.

Edited by Joby Puthuparampil Johnson. It has subsidiaries in Brazil, DubaiNigeria, Singapore and South Africa and branch offices in Morocco and Russiawhich play an important role in its international operations, the release said. It is ranked much higher in the therapeutic areas in which it operates. Blackstone Emcure Bain Capital private equity stake. Emcure is ranked the 14th largest pharmaceutical company in India in terms of market share based on the domestic sales of pharmaceutical products, according to healthcare services information provider IMS Health India.

Thu, Dec 19 Choose your reason below and click on the Report button. Find this comment offensive? Emcure is ranked among the top 15 pharmaceutical companies in India in terms of market share based on the domestic sales of pharmaceutical products. Emcure operates nine manufacturing facilities, eight of which are located in India and one in the United States.

Fri, Dec 20 My Saved Articles Sign in Sign up.

Investment Banking

Fortis again pushes back date to complete RHT Health deal; auditor resigns. To see your saved stories, click on link hightlighted in bold. Emcure Pharmaceuticals withdraws proposed IPO.

  GYGAX CANTING CREW PDF

Technicals Technical Chart Visualize Screener. Emcure Pharmaceuticals acquires Canadian company and its marketing arm Marcan.

Read more on Emcure Pharmaceuticals. Mandhana added that while an IPO is a convenient route for exits, secondary transactions provide more comfort to the new investor as potential corporate governance issues would have already been taken care of by the exiting PE firm.

Emcure Pharmaceuticals withdraws proposed IPO

Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus DRHP with SEBI for initial public offering that includes fresh issue of upto Rs crore and an offer for sale of upto 25,13, equity share. Fill in your details: The issue also involves a secondary sale 2. Blackstone has invested Rs crore in Emcure through convertible shares and currently holds a BSCPL is an infrastructure development company which operates in road, irrigation, real estate and hydro power projects.

British support-services provider Serco Group Plc. For the nine months period ended December This follows a deal struck late last year where Blackstone dryp its stake to Bain Capital for an undisclosed amount. The company commercialises its products through a combination of its own marketing and distribution infrastructure.

Secondary transactions set the ground for appropriate valuations as there is no information arbitrage unlike in a primary transaction.